Surviving Lymphoma: Checkup Anxiety

Many patients become anxious before checkups with their doctor, especially after they enter remission. The idea that the cancer could relapse is extremely frightening and is nothing to be ashamed of. In fact, the reaction is quite normal. After going through harsh treatments like chemotherapy or radiation, it is only natural for patients to be scared of repeating the process if their cancer comes back. The idea that secondary cancers could develop or other late effects could happen is just as scary.

If you feel anxious prior to a doctor’s appointment, then let your physician know. Don’t be afraid to ask questions about all of the tests you go through. Anxiety can lead to restlessness, distraction, and physical illness like nausea, so your doctor should provide you with all of the relief possible. Answering your questions and monitoring your health is the best way for the doctor to help.

Another thing to remember is to have a positive attitude. Happy thoughts can lead to confidence and improve your overall health. Plus, current lymphoma treatments are highly effective in most cases, with survival rates higher than most other cancers. Keep this in mind and continually think of how likely it is that you’ll survive without further problems.

If you find that you cannot calm yourself down, enlist family members or friends. Try soothing activities. In the worst case scenario, your doctor may prescribe anti-anxiety medications.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap